EMORY UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1836-12-10

Employees: 10K

Market Cap: -

Website: http://www.emory.edu

Clinical Trials

Phase 0 Analysis of Ixazomib (MLN9708) in Patients With Glioblastoma

Early Phase 1

Completed

Conditions: Glioblastoma

Interventions: Drug: Ixazomib

First Posted Date: 2015-12-15

Last Posted Date: 2021-03-26

Lead Sponsor: Emory University

Target Recruit Count: 3

Registration Number: NCT02630030

Locations: 🇺🇸
Emory University/Winship Cancer Institute, Atlanta, Georgia, United States

Medication Adherence in Patients With Inflammatory Bowel Disease (IBD)

Not Applicable

Completed

Conditions: Crohn's Disease
Inflammatory Bowel Disease
Ulcerative Colitis

Interventions: Behavioral: Educational Visit
Behavioral: Medication Educational Visit
Behavioral: Education and Reminders
Behavioral: Financial Support

First Posted Date: 2015-12-03

Last Posted Date: 2018-10-01

Lead Sponsor: Emory University

Target Recruit Count: 77

Registration Number: NCT02620514

Locations: 🇺🇸
The Emory Clinic, Atlanta, Georgia, United States

Buparlisib and Ofatumumab or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Phase 1

Terminated

Conditions: Recurrent Chronic Lymphocytic Leukemia
Recurrent Small Lymphocytic Lymphoma
Refractory Chronic Lymphocytic Leukemia
Refractory Small Lymphocytic Lymphoma

Interventions: Drug: Buparlisib
Drug: Ibrutinib
Biological: Ofatumumab

First Posted Date: 2015-11-25

Last Posted Date: 2019-09-03

Lead Sponsor: Emory University

Target Recruit Count: 1

Registration Number: NCT02614508

Locations: 🇺🇸
Emory University/Winship Cancer Institute, Atlanta, Georgia, United States

Community Pediatric Acceptability Study (CPAS)

Not Applicable

Completed

Conditions: Otitis

Interventions: Other: Conventional otoscope
Other: Smartphone otoscope

First Posted Date: 2015-11-20

Last Posted Date: 2016-01-26

Lead Sponsor: Emory University

Target Recruit Count: 75

Registration Number: NCT02610699

Locations: 🇺🇸
Emory Children's Center, Atlanta, Georgia, United States

Acceptability and Feasibility of Micronutrient Powders Versus Iron Syrup for Anemia Prevention in Young Children

Not Applicable

Completed

Conditions: Anemia

Interventions: Dietary Supplement: Iron and Folic Acid (IFA)
Dietary Supplement: Micronutrient Powders (MNP)
Behavioral: Iron Plus Strategy Counseling

First Posted Date: 2015-11-20

Last Posted Date: 2016-04-25

Lead Sponsor: Emory University

Target Recruit Count: 110

Registration Number: NCT02610881

Locations: 🇮🇳
CARE-India, Patna, Bihar, India

Identification and Treatment of Diabetes In Solid Organ Transplant Recipients

Not Applicable

Completed

Conditions: Complications of Transplanted Organs and Tissue

Interventions: Behavioral: Psychologist Support
Behavioral: Pediatric Certified Diabetes Educators (CDEs) Support

First Posted Date: 2015-11-16

Last Posted Date: 2020-12-09

Lead Sponsor: Emory University

Target Recruit Count: 65

Registration Number: NCT02605200

Locations: 🇺🇸
Children's Healthcare of Atlanta-Egleston, Atlanta, Georgia, United States
🇺🇸
Emory Children's Center, Atlanta, Georgia, United States

Suicidal Behavior in Patients Diagnosed With Bipolar Disorder

Not Applicable

Recruiting

Conditions: Alcoholism
Drug Abuse
Depression

Interventions: Behavioral: Interpersonal and Social Rhythm Therapy (ISRT)
Behavioral: Bipolar-Specific Cognitive Behavioral Therapy (CBT)
Behavioral: Mindfulness-Based Stress Reduction (MBSR)
Behavioral: Psycho-education & Understanding Bipolar Medications Therapy

First Posted Date: 2015-11-13

Last Posted Date: 2024-01-31

Lead Sponsor: Emory University

Target Recruit Count: 130

Registration Number: NCT02604277

Locations: 🇺🇸
Grady Health System, Atlanta, Georgia, United States

Anterior Cruciate Ligament Pain Study

Phase 4

Completed

Conditions: Anterior Cruciate Ligament Reconstruction

Interventions: Drug: Ropivacaine 0.5%
Drug: Percocet 7.5/325
Drug: Naprosyn 500 mg

First Posted Date: 2015-11-13

Last Posted Date: 2017-05-31

Lead Sponsor: Emory University

Target Recruit Count: 115

Registration Number: NCT02604550

Locations: 🇺🇸
Emory Healthcare Orthopaedics and Spine Center, Atlanta, Georgia, United States

Home Fortification of Complementary Foods in Bihar India

Not Applicable

Completed

Conditions: Anemia
Malnutrition

Interventions: Dietary Supplement: Home Fortification Product (HFP)
Other: Infant and Young Child Feeding (IYCF) Practices Counseling

First Posted Date: 2015-10-30

Last Posted Date: 2017-03-14

Lead Sponsor: Emory University

Target Recruit Count: 11861

Registration Number: NCT02593136

Locations: 🇮🇳
CARE-India, Patna, Bihar, India

Vitamin D and Microbiota in Cystic Fibrosis

Not Applicable

Completed

Conditions: Vitamin D Deficiency
Cystic Fibrosis

Interventions: Dietary Supplement: High-Dose Vitamin D3
Other: Sputum Sample
Other: Stool Sample
Other: Sham Comparator
Procedure: Blood draw

First Posted Date: 2015-10-28

Last Posted Date: 2017-06-14

Lead Sponsor: Emory University

Target Recruit Count: 41

Registration Number: NCT02589444

Locations: 🇺🇸
Emory Clinic, Atlanta, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy